SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ping Zhang, Ashley E. Culver-Cochran, Stanley M. Stevens, Bin Liu, Characterization of a SILAC method for proteomic analysis of primary rat microglia, PROTEOMICS, 2016, 16, 8
  2. 2
    Flávia V. Santa-Cecília, Benjamin Socias, Mohand O. Ouidja, Julia E. Sepulveda-Diaz, Leonardo Acuña, Rangel L. Silva, Patrick P. Michel, Elaine Del-Bel, Thiago M. Cunha, Rita Raisman-Vozari, Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways, Neurotoxicity Research, 2016, 29, 4, 447

    CrossRef

  3. 3
    Qing He, Yan-hua Li, Si-si Guo, Ying Wang, Wei Lin, Qiong Zhang, Jian Wang, Cun-gen Ma, Bao-Guo Xiao, Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model, European Journal of Neuroscience, 2016, 43, 1
  4. 4
    Amos D. Korczyn, Sharon Hassin-Baer, Can the disease course in Parkinson’s disease be slowed?, BMC Medicine, 2015, 13, 1

    CrossRef

  5. 5
    Neha Sharma, Bimla Nehru, Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation, Neurochemistry International, 2015, 87, 92

    CrossRef

  6. 6
    Kuo-Mao Lan, Lu-Tai Tien, Yi Pang, Abhay J. Bhatt, Lir-Wan Fan, IL-1 receptor antagonist attenuates neonatal lipopolysaccharide-induced long-lasting learning impairment and hippocampal injury in adult rats, Toxicology Letters, 2015, 234, 1, 30

    CrossRef

  7. 7
    Yi Pang, Lu-Tai Tien, Hobart Zhu, Juying Shen, Camilla Wright, Tembra Jones, Samir Mamoon, Abhay Bhatt, Zhengwei Cai, Lir-Wan Fan, Interleukin-1 Receptor Antagonist Reduces Neonatal Lipopolysaccharide-Induced Long-Lasting Neurobehavioral Deficits and Dopaminergic Neuronal Injury in Adult Rats, International Journal of Molecular Sciences, 2015, 16, 4, 8635

    CrossRef

  8. 8
    Yan Zhu, Xiao Chen, Zhan Liu, Yu-Ping Peng, Yi-Hua Qiu, Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures, International Journal of Molecular Sciences, 2015, 17, 1, 25

    CrossRef

  9. 9
    Yan-Hua Li, Qing He, Jie-zhong Yu, Chun-yun Liu, Ling Feng, Zhi Chai, Qing Wang, Hong-zhen Zhang, Guang-Xian Zhang, Bao-guo Xiao, Cun-gen Ma, Lipoic acid protects dopaminergic neurons in LPS-induced Parkinson’s disease model, Metabolic Brain Disease, 2015, 30, 5, 1217

    CrossRef

  10. 10
    Arpita Sharma, Nisha Patro, Ishan K. Patro, Lipopolysaccharide-Induced Apoptosis of Astrocytes: Therapeutic Intervention by Minocycline, Cellular and Molecular Neurobiology, 2015,

    CrossRef

  11. 11
    Anat Shemer, Daniel Erny, Steffen Jung, Marco Prinz, Microglia Plasticity During Health and Disease: An Immunological Perspective, Trends in Immunology, 2015, 36, 10, 614

    CrossRef

  12. 12
    Pablo Granados-Durán, María D. López-Ávalos, Jesús M. Grondona, María del Carmen Gómez-Roldán, Manuel Cifuentes, Margarita Pérez-Martín, Martina Alvarez, Fernando Rodríguez de Fonseca, Pedro Fernández-Llebrez, Neuroinflammation Induced by Intracerebroventricular Injection of Microbial Neuraminidase, Frontiers in Medicine, 2015, 2,

    CrossRef

  13. 13
    Xin Fang, Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis, International Journal of Neuroscience, 2015, 1

    CrossRef

  14. 14
    Jose A. Morales-Garcia, Diana Aguilar-Morante, Elena Hernandez-Encinas, Sandra Alonso-Gil, Carmen Gil, Ana Martinez, Angel Santos, Ana Perez-Castillo, Silencing phosphodiesterase 7B gene by lentiviral-shRNA interference attenuates neurodegeneration and motor deficits in hemiparkinsonian mice, Neurobiology of Aging, 2015, 36, 2, 1160

    CrossRef

  15. 15
    Hannah R. Wardill, Ysabella Z.A. Van Sebille, Kimberley A. Mander, Rachel J. Gibson, Richard M. Logan, Joanne M. Bowen, Stephen T. Sonis, Toll-like receptor 4 signaling: A common biological mechanism of regimen-related toxicities, Cancer Treatment Reviews, 2015, 41, 2, 122

    CrossRef

  16. 16
    Teresa Trotta, Chiara Porro, Rosa Calvello, Maria Antonietta Panaro, Biological role of Toll-like receptor-4 in the brain, Journal of Neuroimmunology, 2014, 268, 1-2, 1

    CrossRef

  17. 17
    Massimo Lazzaro, Barbara Bettegazzi, Marco Barbariga, Franca Codazzi, Daniele Zacchetti, Massimo Alessio, Ceruloplasmin potentiates nitric oxide synthase activity and cytokine secretion in activated microglia, Journal of Neuroinflammation, 2014, 11, 1

    CrossRef

  18. 18
    Francisco Pan-Montojo, Heinz Reichmann, Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology, Translational Neurodegeneration, 2014, 3, 1, 10

    CrossRef

  19. 19
    Katherine M. Rose, Mayur S. Parmar, Jane E. Cavanaugh, Dietary supplementation with resveratrol protects against striatal dopaminergic deficits produced by in utero LPS exposure, Brain Research, 2014, 1573, 37

    CrossRef

  20. 20
    Dorit Trudler, Orly Weinreb, Silvia A. Mandel, Moussa B. H. Youdim, Dan Frenkel, DJ-1 deficiency triggers microglia sensitivity to dopamine toward a pro-inflammatory phenotype that is attenuated by rasagiline, Journal of Neurochemistry, 2014, 129, 3
  21. 21
    Uta Rickert, Steffen Grampp, Henrik Wilms, Jessica Spreu, Friederike Knerlich-Lukoschus, Janka Held-Feindt, Ralph Lucius, Glial Cell Line-Derived Neurotrophic Factor Family Members Reduce Microglial Activation via Inhibiting p38MAPKs-Mediated Inflammatory Responses, Journal of Neurodegenerative Diseases, 2014, 2014, 1

    CrossRef

  22. 22
    Xiaohua Deng, Meili Li, Weiming Ai, Lixin He, Dahua Lu, Peter R. Patrylo, Huaibin Cai, Xuegang Luo, Zhiyuan Li, Xiao-Xin Yan, Lipolysaccharide-Induced Neuroinflammation Is Associated with Alzheimer-Like Amyloidogenic Axonal Pathology and Dendritic Degeneration in Rats, Advances in Alzheimer's Disease, 2014, 03, 02, 78

    CrossRef

  23. 23
    Samuel M. Goldman, Freya Kamel, G. Webster Ross, Sarah A. Jewell, Connie Marras, Jane A. Hoppin, David M. Umbach, Grace S. Bhudhikanok, Cheryl Meng, Monica Korell, Kathleen Comyns, Robert A. Hauser, Joseph Jankovic, Stewart A. Factor, Susan Bressman, Kelly E. Lyons, Dale P. Sandler, J. William Langston, Caroline M. Tanner, Peptidoglycan recognition protein genes and risk of Parkinson's disease, Movement Disorders, 2014, 29, 9
  24. 24
    Burak Yulug, Lütfü Hanoglu, Ertugrul Kilic, Wolf Rüdiger Schabitz, RIFAMPICIN: An antibiotic with brain protective function, Brain Research Bulletin, 2014, 107, 37

    CrossRef

  25. 25
    Wei Zhang, Zhao-fen Yan, Jun-hua Gao, Li Sun, Xi-yan Huang, Zhuo Liu, Shu-yang Yu, Chen-Jie Cao, Li-jun Zuo, Ze-Jie Chen, Yang Hu, Fang Wang, Jau-shyong Hong, Xiao-min Wang, Role and Mechanism of Microglial Activation in Iron-Induced Selective and Progressive Dopaminergic Neurodegeneration, Molecular Neurobiology, 2014, 49, 3, 1153

    CrossRef

  26. 26
    C.C. Real, A.F.B. Ferreira, G.P. Chaves-Kirsten, A.S. Torrão, R.S. Pires, L.R.G. Britto, BDNF receptor blockade hinders the beneficial effects of exercise in a rat model of Parkinson’s disease, Neuroscience, 2013, 237, 118

    CrossRef

  27. 27
    Deirdre B. Hoban, Emer Connaughton, Catherine Connaughton, Grace Hogan, Chloe Thornton, Padraig Mulcahy, Teresa C. Moloney, Eilis Dowd, Further characterisation of the LPS model of Parkinson’s disease: A comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat, Brain, Behavior, and Immunity, 2013, 27, 91

    CrossRef

  28. 28
    J. A. Morales-García, C. Susín, S. Alonso-Gil, D. I. Pérez, V. Palomo, C. Pérez, S. Conde, A. Santos, C. Gil, A. Martínez, A. Pérez-Castillo, Glycogen Synthase Kinase-3 Inhibitors as Potent Therapeutic Agents for the Treatment of Parkinson Disease., ACS Chemical Neuroscience, 2013, 4, 2, 350

    CrossRef

  29. 29
    Marie-Francoise Doursout, Michael S. Schurdell, Lauren M. Young, Uzondu Osuagwu, Diana M. Hook, Brian J. Poindexter, Mya C. Schiess, Diane L. M. Bick, Roger J. Bick, Inflammatory Cells and Cytokines in the Olfactory Bulb of a Rat Model of Neuroinflammation; Insights into Neurodegeneration?, Journal of Interferon & Cytokine Research, 2013, 33, 7, 376

    CrossRef

  30. 30
    Jason R. Richardson, Muhammad M. Hossain, Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson’s Disease, Neural Plasticity, 2013, 2013, 1

    CrossRef

  31. 31
    Anna R. Carta, Augusta Pisanu, Modulating Microglia Activity with PPAR-γ Agonists: A Promising Therapy for Parkinson’s Disease?, Neurotoxicity Research, 2013, 23, 2, 112

    CrossRef

  32. 32
    K.-C. Wang, L.-W. Fan, A. Kaizaki, Y. Pang, Z. Cai, L.-T. Tien, Neonatal lipopolysaccharide exposure induces long-lasting learning impairment, less anxiety-like response and hippocampal injury in adult rats, Neuroscience, 2013, 234, 146

    CrossRef

  33. 33
    Jieming Ye, Zhenhua Liu, Jipeng Wei, Lingli Lu, Yanjun Huang, Lili Luo, Huifang Xie, Protective effect of SIRT1 on toxicity of microglial-derived factors induced by LPS to PC12 cells via the p53-caspase-3-dependent apoptotic pathway, Neuroscience Letters, 2013, 553, 72

    CrossRef

  34. 34
    Harris Bell-Temin, Ping Zhang, Dale Chaput, Michael A. King, Min You, Bin Liu, Stanley M. Stevens, Quantitative Proteomic Characterization of Ethanol-Responsive Pathways in Rat Microglial Cells, Journal of Proteome Research, 2013, 12, 5, 2067

    CrossRef

  35. 35
    Wei Bi, Lihong Zhu, Xiuna Jing, Yanran Liang, Enxiang Tao, Rifampicin and Parkinson’s disease, Neurological Sciences, 2013, 34, 2, 137

    CrossRef

  36. 36
    Rui Zhang, Ming Zhao, Hai-jie Ji, Yu-he Yuan, Nai-hong Chen, Study on the Dynamic Changes in Synaptic Vesicle-Associated Protein and Axonal Transport Protein Combined with LPS Neuroinflammation Model, ISRN Neurology, 2013, 2013, 1

    CrossRef

  37. 37
    Randall L. Davis, Subhas Das, Daniel J. Buck, Craig W. Stevens, β-Funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes, Neurochemistry International, 2013, 62, 4, 478

    CrossRef

  38. 38
    Manila Candiracci, Elena Piatti, María Dominguez-Barragán, Daniel García-Antrás, Bruno Morgado, Diego Ruano, Juan F. Gutiérrez, Juan Parrado, Angélica Castaño, Anti-inflammatory Activity of a Honey Flavonoid Extract on Lipopolysaccharide-Activated N13 Microglial Cells, Journal of Agricultural and Food Chemistry, 2012, 60, 50, 12304

    CrossRef

  39. 39
    Patrick Oeckl, Michael Lattke, Thomas Wirth, Bernd Baumann, Boris Ferger, Astrocyte-specific IKK2 activation in mice is sufficient to induce neuroinflammation but does not increase susceptibility to MPTP, Neurobiology of Disease, 2012, 48, 3, 481

    CrossRef

  40. 40
    Hanna S. Lindgren, Stephen B. Dunnett, Cognitive dysfunction and depression in Parkinson’s disease: what can be learned from rodent models?, European Journal of Neuroscience, 2012, 35, 12
  41. 41
    Louise M. Collins, André Toulouse, Thomas J. Connor, Yvonne M. Nolan, Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease, Neuropharmacology, 2012, 62, 7, 2154

    CrossRef

  42. 42
    Donna M. Crabtree, Jianhua Zhang, Genetically engineered mouse models of Parkinson's disease, Brain Research Bulletin, 2012, 88, 1, 13

    CrossRef

  43. 43
    Garima Dutta, David S. Barber, Ping Zhang, Nicholas J. Doperalski, Bin Liu, Involvement of dopaminergic neuronal cystatin C in neuronal injury-induced microglial activation and neurotoxicity, Journal of Neurochemistry, 2012, 122, 4
  44. 44
    Soo Kyung Ahn, Samin Hong, Yu Mi Park, Ja Yong Choi, Won Taek Lee, Kyung Ah Park, Jong Eun Lee, Protective effects of agmatine on lipopolysaccharide-injured microglia and inducible nitric oxide synthase activity, Life Sciences, 2012, 91, 25-26, 1345

    CrossRef

  45. 45
    P.R. Mouton, B. Kelley-Bell, D. Tweedie, E.L. Spangler, E. Perez, O.D. Carlson, R.G. Short, R. deCabo, J. Chang, D.K. Ingram, Y. Li, N.H. Greig, The effects of age and lipopolysaccharide (LPS)-mediated peripheral inflammation on numbers of central catecholaminergic neurons, Neurobiology of Aging, 2012, 33, 2, 423.e27

    CrossRef

  46. 46
    Anna R. Carta, The role of microglia–lymphocyte interaction in PD neuropathology, Basal Ganglia, 2012, 2, 3, 123

    CrossRef

  47. 47
    Yun-Hee Sung, Shin-Chul Kim, Hoon-Pyo Hong, Chang-Youl Park, Mal-Soon Shin, Chang-Ju Kim, Jin-Hee Seo, Dae-Young Kim, Dong-Je Kim, Han-Jin Cho, Treadmill exercise ameliorates dopaminergic neuronal loss through suppressing microglial activation in Parkinson's disease mice, Life Sciences, 2012, 91, 25-26, 1309

    CrossRef

  48. 48
    Yuan Liu, Jun Hu, Jie Wu, Chenlei Zhu, Yujian Hui, Yaping Han, Zuhu Huang, Kevin Ellsworth, Weimin Fan, α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation, Journal of Neuroinflammation, 2012, 9, 1, 98

    CrossRef

  49. 49
    Sarika Singh, Supriya Swarnkar, Poonam Goswami, Chandishwar Nath, Astrocytes and Microglia: Responses to Neuropathological Conditions, International Journal of Neuroscience, 2011, 121, 11, 589

    CrossRef

  50. 50
    Yeong-Gon Choi, Sujung Yeo, Yeon-Mi Hong, Sung-Hoon Kim, Sabina Lim, Changes of gene expression profiles in the cervical spinal cord by acupuncture in an MPTP-intoxicated mouse model: Microarray analysis, Gene, 2011, 481, 1, 7

    CrossRef

  51. 51
    Xudong Xu, Qing Zhang, Jianqi Tu, Zhenfeng Ren, D-β-hydroxybutyrate inhibits microglial activation in a cell activation model in vitro, Journal of Medical Colleges of PLA, 2011, 26, 3, 117

    CrossRef

  52. 52
    Xi-Jin Wang, Shi Zhang, Zhi-Qiang Yan, Yan-Xin Zhao, Hai-Yan Zhou, Ying Wang, Guo-Qiang Lu, Jing-Dong Zhang, Impaired CD200–CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: Roles of aging, superoxide, NADPH oxidase, and p38 MAPK, Free Radical Biology and Medicine, 2011, 50, 9, 1094

    CrossRef

  53. 53
    Kaoru Saijo, Christopher K. Glass, Microglial cell origin and phenotypes in health and disease, Nature Reviews Immunology, 2011, 11, 11, 775

    CrossRef

  54. 54
    Lir-Wan Fan, Lu-Tai Tien, Rick C.S. Lin, Kimberly L. Simpson, Philip G. Rhodes, Zhengwei Cai, Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life, Neurobiology of Disease, 2011, 44, 3, 304

    CrossRef

  55. 55
    Tiziana Alberio, Mauro Fasano, Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies, Journal of Biotechnology, 2011, 156, 4, 325

    CrossRef

  56. 56
    Cristina Pintado, Elisa Revilla, María L. Vizuete, Sebastián Jiménez, Luisa García-Cuervo, Javier Vitorica, Diego Ruano, Angélica Castaño, Regional difference in inflammatory response to LPS-injection in the brain: Role of microglia cell density, Journal of Neuroimmunology, 2011, 238, 1-2, 44

    CrossRef

  57. 57
    Francesca L'Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria Concetta Morale, Francesco Impagnatiello, Bianca Marchetti, Switching the Microglial Harmful Phenotype Promotes Lifelong Restoration of Subtantia Nigra Dopaminergic Neurons from Inflammatory Neurodegeneration in Aged Mice, Rejuvenation Research, 2011, 14, 4, 411

    CrossRef

  58. 58
    Amit Bar-Or, Peter Rieckmann, Anthony Traboulsee, V. Wee Yong, Targeting Progressive Neuroaxonal Injury, CNS Drugs, 2011, 25, 9, 783

    CrossRef

  59. 59
    Kemal Ugur Tufekci, Sermin Genc, Kursad Genc, The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  60. 60
    Ronise M. Santiago, Janaína Barbieiro, Marcelo M.S. Lima, Patrícia A. Dombrowski, Roberto Andreatini, Maria A.B.F. Vital, Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010, 34, 6, 1104

    CrossRef

  61. 61
    Deborah Ariza, Marcelo M. S. Lima, Camila G. Moreira, Patrícia A. Dombrowski, Thiago V. Avila, Alexandra Allemand, Daniel A. G. B Mendes, Claudio Da Cunha, Maria A. B. F. Vital, Intranigral LPS Administration Produces Dopamine, Glutathione but not Behavioral Impairment in Comparison to MPTP and 6-OHDA Neurotoxin Models of Parkinson’s Disease, Neurochemical Research, 2010, 35, 10, 1620

    CrossRef

  62. 62
    Malú G. Tansey, Matthew S. Goldberg, Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention, Neurobiology of Disease, 2010, 37, 3, 510

    CrossRef

  63. 63
    Ping Zhang, Kyle M. Lokuta, DeAnne E. Turner, Bin Liu, Synergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia, Journal of Neurochemistry, 2010, 112, 2
  64. 64
    Dorit Trudler, Dorit Farfara, Dan Frenkel, Toll-Like Receptors Expression and Signaling in Glia Cells in Neuro-Amyloidogenic Diseases: Towards Future Therapeutic Application, Mediators of Inflammation, 2010, 2010, 1

    CrossRef

  65. 65
    Julius Benicky, Enrique Sánchez-Lemus, Jaroslav Pavel, Juan M. Saavedra, Anti-Inflammatory Effects of Angiotensin Receptor Blockers in the Brain and the Periphery, Cellular and Molecular Neurobiology, 2009, 29, 6-7, 781

    CrossRef

  66. 66
    Anjana Yadav, Ronald G. Collman, CNS Inflammation and Macrophage/Microglial Biology Associated with HIV-1 Infection, Journal of Neuroimmune Pharmacology, 2009, 4, 4, 430

    CrossRef

  67. 67
    Justin A. McClain, Linda L. Phillips, Helen L. Fillmore, Increased MMP-3 and CTGF expression during lipopolysaccharide-induced dopaminergic neurodegeneration, Neuroscience Letters, 2009, 460, 1, 27

    CrossRef

  68. 68
    Yi Sui, Davor Stanić, Doris Tomas, Bevyn Jarrott, Malcolm K. Horne, Meloxicam reduces lipopolysaccharide-induced degeneration of dopaminergic neurons in the rat substantia nigra pars compacta, Neuroscience Letters, 2009, 460, 2, 121

    CrossRef

  69. 69
    Ping Zhang, Tamika A. Wong, Kyle M. Lokuta, DeAnne E. Turner, Kristina Vujisic, Bin Liu, Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: Role of free radical generation, Experimental Neurology, 2009, 217, 1, 219

    CrossRef

  70. 70
    Bernardino Ossola, Tiina M Kääriäinen, Pekka T Männistö, The multiple faces of quercetin in neuroprotection, Expert Opinion on Drug Safety, 2009, 8, 4, 397

    CrossRef

  71. 71
    Rajiv Tikamdas, Ping Zhang, Bin Liu, Mediators of neuroinflammation,